Erik Hillesland, et al v. Glenmark Pharmaceuticals, Inc. USA, et al, et al
| GLENMARK PHARMACEUTICALS, INC. USA, APOTEX CORP., MICHAEL MCCANDLESS, BRAD ALDRIDGE, AJANTA PHARMA USA, INC., AURO HEALTH LLC, BOEHRINGER INGELHEIM CORPORATION, CONTRACT PHARMACAL CORP., DR. REDDY'S LABORATORIES, LTD. and GLAXOSMITHKLINE (AMERICA) INC. |
| ERIK ROY HILLESLAND |
| 23-14181 |
| December 27, 2023 |
| U.S. Court of Appeals, Eleventh Circuit |
| Health Care / Pharma |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 23, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 9
Judgment entered as to Appellant Erik Roy Hillesland. [Entered: 02/23/2024 10:01 AM]
|
|
Filing 8
Opinion issued by court as to Appellant Erik Roy Hillesland. Decision: Dismissed. Opinion type: Non-Published. Opinion method: Per Curiam. The opinion is also available through the Court's Opinions page at this link # http://www.ca11.uscourts.gov/opinions . [Entered: 02/23/2024 09:58 AM]
|
|
Filing 7
Appendix filed [1 VOLUMES] by Party Erik Roy Hillesland. Service date: 02/02/2024 email - Attorney for Appellees: Bandy, Bayman, Berman, Bucciero, Eisenstein, Henry, Ipsaro, Kernisky, McVeigh, Rothschild, Seth, Winters, Yoo. [Entered: 02/02/2024 04:36 PM]
|
|
Filing 5
Briefing Notice issued to Appellant Erik Roy Hillesland. The appellant's brief is due on or before 02/05/2024. The appendix is due no later than 7 days from the filing of the appellant's brief. [Entered: 01/17/2024 02:56 PM]
|
|
Filing 4
Appellant's Certificate of Interested Persons and Corporate Disclosure Statement filed by Appellant Erik Roy Hillesland. [Entered: 01/17/2024 02:55 PM]
|
|
Filing 3
TRANSCRIPT INFORMATION form filed by Party Erik Roy Hillesland. No transcript is required for appeal purposes. [Entered: 01/17/2024 02:53 PM]
|
|
Filing 6
Appellant's brief filed by Erik Roy Hillesland. Service date: 01/29/2024 [23-14181] Attorney for Appellee: Bandy - email; Attorney for Appellee: Bayman - email; Attorney for Appellee: Berman - email; Attorney for Appellee: Bucciero - email; Attorney for Appellee: Eisenstein - email; Attorney for Appellee: Henry - email; Attorney for Appellee: Ipsaro - email; Attorney for Appellee: Kernisky - email; Attorney for Appellee: McVeigh - email; Attorney for Appellee: Rothschild - email; Attorney for Appellee: Seth - email; Attorney for Appellee: Winters - email; Attorney for Appellee: Yoo - email. [Entered: 01/29/2024 01:44 PM]
|
|
Filing 2
Appellate fee was paid on 12/22/2023 as to Appellant Erik Roy Hillesland. [Entered: 01/02/2024 12:26 PM]
|
|
Filing 1
CIVIL APPEAL DOCKETED. Notice of appeal filed by Appellant Erik Roy Hillesland on 12/18/2023. Fee Status: Fee Paid. Awaiting Appellant's Certificate of Interested Persons due on or before 01/16/2024 as to Appellant Erik Roy Hillesland. Awaiting Appellee's Certificate of Interested Persons due on or before 01/30/2024 as to Appellees Ajanta Pharma USA, Inc., Brad Aldridge, Apotex Corp., Auro Health LLC, Boehringer Ingelheim Corporation, Contract Pharmacal Corp., Dr. Reddy's Laboratories, Ltd., Glenmark Pharmaceuticals, Inc. USA and Michael McCandless [Entered: 01/02/2024 12:19 PM]
|
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
